RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia. (2020)
Attributed to:
Finding therapeutic targets in FLT3-ITD AML using a systems biology approach
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.exphem.2020.10.005
PubMed Identifier: 33152396
Publication URI: http://europepmc.org/abstract/MED/33152396
Type: Journal Article/Review
Volume: 92
Parent Publication: Experimental hematology
ISSN: 0301-472X